MHV Labs is the company conception and formation process of Militia Hill Ventures.  Through the MHV network of industry and academic experts, MHV Labs is where the best company ideas are discussed, evaluated and incubated.

MHV Labs employs an active build model to form and develop new ventures focused on therapeutics with active operational involvement at every stage of the process from conception through operation.  Once an unaddressed medical need is identified and selected, a comprehensive global evaluation is conducted of all applicable technologies and solutions.  The best technology and talent is acquired, and a business plan is developed to commercialize the technology most effectively.  MHV Labs then launches a company, builds the management team, and secures the necessary financing to develop the technology efficiently.  

MHV Labs Team

ABOUT

Hope assists in new company formation, technology transfer and regulatory affairs for MHV Labs. Hope is a life sciences corporate attorney with extensive law firm and in-house experience, including at a one of the largest global pharmaceutical companies.

Hope D’Oyley-Gay, JD

ABOUT

Mike assists scientific due diligence and business development strategy for MHV Labs. Mike brings decades of industry experience with expertise in multiple therapeutic areas including metabolic disease, neurodegenerative and neurological disorders and inflammatory diseases.

Michael Saporito, PhD

ABOUT

Bill assists in scientific diligence and company evaluation for MHV Labs. Trained as a systems neuroscientists, Bill has extensive drug development and company formation expertise. Bill has led drug discovery and R&D groups and has helped advance more than 10 novel chemical entities into the clinic.

William Martin, PhD

ABOUT

Rob assists in scientific diligence and business strategy development for MHV Labs. Rob brings more than 20 years of experience in building and leading technology-based teams across a variety of therapeutic areas and platforms.

Robert Willenbucher, MD

ABOUT

Eric assists in the clinical development and regulatory affairs for MHV Labs and also serves as Chief Medical Officer of Talee Bio. Eric is a clinical development physician with over 20 years of experience in academia and industry.

Eric Yuen, MD